다우존스 지수

무료로 등록하여 실시간 주식 시세, 대화형 차트, 실시간 옵션 플로우 등을 받아보세요.

등록

PGEN

Precigen (PGEN)

Precigen Inc

일자:

규정 관련뉴스

텍스트 검색:

정렬 기준:

규정 외 뉴스

검색 관련기사 보기:NASDAQ:PGEN

1 2 3 4 5 6 7 8 9 10 다음 >>

일자	시간	출처	헤드라인	심볼	기업
2024/05/09	05:05	PR Newswire (US)	Precigen to Announce First Quarter 2024 Financial Results on May 14th and Host a Conference Call on June 3rd following the Late-breaking Oral Presentation for PRGN-2012 at the 2024 ASCO Annual Meeting	NASDAQ:PGEN	Precigen Inc
2024/04/24	23:20	PR Newswire (US)	Precigen to Present Late-breaking Abstract for Pivotal Phase 2 Study Data for PRGN-2012 AdenoVerse Immunotherapy for the Treatment of Patients with Recurrent Respiratory Papillomatosis at the 2024 ASCO Annual Meeting	NASDAQ:PGEN	Precigen Inc
2024/04/24	22:00	PR Newswire (US)	Actym Therapeutics Appoints Thomas Smart as CEO	NASDAQ:PGEN	Precigen Inc
2024/03/29	05:05	PR Newswire (US)	Precigen and Recurrent Respiratory Papillomatosis Foundation to Hold Inaugural International RRP Awareness Day on June 11th	NASDAQ:PGEN	Precigen Inc
2024/03/20	05:05	PR Newswire (US)	Precigen Reports Full Year 2023 Financial Results and Business Updates	NASDAQ:PGEN	Precigen Inc
2024/03/19	20:27	IH Market News	US Index Futures Decline Ahead of Federal Reserve Meeting, Oil Prices Retreat	NASDAQ:PGEN	Precigen Inc
2024/03/13	05:05	PR Newswire (US)	Precigen to Participate in a Fireside Chat Hosted by Cantor Fitzgerald to Discuss PRGN-2012 AdenoVerse Immunotherapy for the Treatment of Recurrent Respiratory Papillomatosis	NASDAQ:PGEN	Precigen Inc
2024/03/06	06:05	PR Newswire (US)	Precigen to Announce Fourth Quarter and Full Year 2023 Financial Results on March 19th	NASDAQ:PGEN	Precigen Inc
2024/02/28	03:48	Edgar (US Regulatory)	Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]	NASDAQ:PGEN	Precigen Inc
2024/02/15	06:00	Edgar (US Regulatory)	Form SC 13G - Statement of acquisition of beneficial ownership by individuals	NASDAQ:PGEN	Precigen Inc
2024/02/15	05:20	Edgar (US Regulatory)	Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]	NASDAQ:PGEN	Precigen Inc
2024/02/09	06:25	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:PGEN	Precigen Inc
2024/02/07	06:05	PR Newswire (US)	Precigen to Participate in the Oppenheimer 34th Annual Healthcare Life Sciences Conference	NASDAQ:PGEN	Precigen Inc
2024/01/18	14:15	Edgar (US Regulatory)	Form EFFECT - Notice of Effectiveness	NASDAQ:PGEN	Precigen Inc
2024/01/16	22:05	PR Newswire (US)	Precigen Receives Orphan Drug Designation for PRGN-2012 for the Treatment of Recurrent Respiratory Papillomatosis from the European Commission	NASDAQ:PGEN	Precigen Inc
2024/01/08	22:39	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:PGEN	Precigen Inc
2024/01/08	22:30	PR Newswire (US)	Precigen Highlights Pipeline Updates to be Presented at the 42nd Annual J.P. Morgan Healthcare Conference	NASDAQ:PGEN	Precigen Inc
2023/12/30	07:26	Edgar (US Regulatory)	Form S-3 - Registration statement under Securities Act of 1933	NASDAQ:PGEN	Precigen Inc
2023/12/19	06:05	PR Newswire (US)	Precigen to Present at the 42nd Annual J.P. Morgan Healthcare Conference	NASDAQ:PGEN	Precigen Inc
2023/11/30	06:05	PR Newswire (US)	Precigen to Participate in the JMP Securities Hematology and Oncology Summit	NASDAQ:PGEN	Precigen Inc
2023/11/10	07:08	Edgar (US Regulatory)	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	NASDAQ:PGEN	Precigen Inc
2023/11/10	07:07	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:PGEN	Precigen Inc
2023/11/10	06:55	PR Newswire (US)	Precigen Reports Third Quarter 2023 Financial Results and Progress of Clinical Programs	NASDAQ:PGEN	Precigen Inc
2023/11/08	06:05	PR Newswire (US)	Precigen to Participate in the Stifel 2023 Healthcare Conference	NASDAQ:PGEN	Precigen Inc
2023/09/20	05:05	PR Newswire (US)	Precigen to Participate in Upcoming Leading Investor and Industry Conferences	NASDAQ:PGEN	Precigen Inc
2023/08/26	08:04	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:PGEN	Precigen Inc
2023/08/26	08:03	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:PGEN	Precigen Inc
2023/08/26	08:01	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:PGEN	Precigen Inc
2023/08/26	08:00	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:PGEN	Precigen Inc
2023/08/26	07:59	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:PGEN	Precigen Inc

검색 관련기사 보기:NASDAQ:PGEN

1 2 3 4 5 6 7 8 9 10 다음 >>

Gold vs US Dollar

US Dollar vs Euro

US Dollar vs Sterling

BNP Paribas (QX)

Energy Select Sector SPDR

Bank of America

American Express

Delayed Upgrade Clock

도움 및 지원받기: kr-support@advfn.com

ADVFN 서비스 이용은 ADVFN의 이용약관에 동의하는 것입니다 이용약관